Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-05-22 4:33 pm Purchase | 13G | MiNK Therapeutics Inc. INKT | GKCC LLC | 4,640,000 11.790% | 4,640,000 (New Position) | View |
| 2024-02-14 6:05 pm Purchase | 13D | MiNK Therapeutics Inc. INKT | ARMEN GARO H | 3,514,320 9.680% | 897,438 (+34.29%) | View |
| 2023-05-26 5:03 pm Purchase | 13D | MiNK Therapeutics Inc. INKT | AGENUS INC AGEN | 21,522,157 62.500% | 177,472 (+0.83%) | View |
| 2023-05-03 5:23 pm Sale | 13D | MiNK Therapeutics Inc. INKT | AGENUS INC AGEN | 21,344,685 62.000% | -4,988,273 (-18.94%) | View |
| 2022-02-14 4:06 pm Purchase | 13G | MiNK Therapeutics Inc. INKT | ARMEN GARO H | 2,616,882 7.820% | 2,616,882 (New Position) | View |
| 2021-10-28 4:30 pm Purchase | 13D | MiNK Therapeutics Inc. INKT | AGENUS INC AGEN | 26,332,958 79.800% | 26,332,958 (New Position) | View |